Published in Oncol Nurs Forum on March 01, 2012
Are we being overly cautious? A qualitative inquiry into the experiences and perceptions of treatment-focused germline BRCA genetic testing amongst women recently diagnosed with breast cancer. Support Care Cancer (2012) 0.89
Health professionals' evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer. Fam Cancer (2015) 0.80
Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider. J Community Genet (2012) 0.79
Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study. J Genet Couns (2016) 0.78
How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age. Mol Genet Genomic Med (2016) 0.75
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet (2010) 9.72
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol (2012) 3.86
Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst (2002) 3.46
Intraoperative radiotherapy for breast cancer. Lancet Oncol (2004) 2.91
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res (2006) 2.05
MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology (2005) 1.94
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet (2012) 1.84
TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol (2005) 1.83
A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol (2012) 1.80
Pregnancy after breast cancer: population based study. BMJ (2006) 1.55
Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations. Clin Cancer Res (2013) 1.54
Multidisciplinary cancer care in Australia: a national audit highlights gaps in care and medico-legal risk for clinicians. Asia Pac J Clin Oncol (2011) 1.43
Assessment of the content and process of genetic counseling: a critical review of empirical studies. J Genet Couns (2008) 1.40
Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Hum Mutat (2011) 1.38
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Res (2012) 1.38
Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysis. BMC Cancer (2008) 1.37
Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome. Clin Cancer Res (2012) 1.35
Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery. Int J Radiat Oncol Biol Phys (2010) 1.24
Volatile biomarkers in the breath of women with breast cancer. J Breath Res (2010) 1.23
Fast track referral for cancer. BMJ (2007) 1.23
Synthetic lethality between CCNE1 amplification and loss of BRCA1. Proc Natl Acad Sci U S A (2013) 1.22
Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families. Cancer Prev Res (Phila) (2011) 1.21
Parametric imaging of cancer with optical coherence tomography. J Biomed Opt (2010) 1.21
Imaging of human lymph nodes using optical coherence tomography: potential for staging cancer. Cancer Res (2010) 1.19
Predictors of relapse to harmful alcohol after orthotopic liver transplantation. Alcohol Alcohol (2006) 1.19
Diagnosing cancer in the bush: a mixed-methods study of symptom appraisal and help-seeking behaviour in people with cancer from rural Western Australia. Fam Pract (2013) 1.16
Is it safe and efficacious for women with lymphedema secondary to breast cancer to lift heavy weights during exercise: a randomised controlled trial. J Cancer Surviv (2013) 1.13
A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes. BMC Cancer (2011) 1.12
Flexible surgical training: it is time for change. ANZ J Surg (2012) 1.07
Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda. Breast Cancer Res (2008) 1.05
Mutation analysis of the MYH gene in an Australian series of colorectal polyposis patients with or without germline APC mutations. Int J Cancer (2005) 1.02
Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk. Cancer (2008) 1.01
The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS One (2010) 1.01
Male breast ductal carcinoma in situ. ANZ J Surg (2003) 1.00
Exercise for health: a randomized, controlled trial evaluating the impact of a pragmatic, translational exercise intervention on the quality of life, function and treatment-related side effects following breast cancer. Breast Cancer Res Treat (2012) 0.99
The Angelina Jolie effect. Med J Aust (2013) 0.99
A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Res Treat (2007) 0.97
Women's experience of telehealth cancer genetic counseling. J Genet Couns (2010) 0.97
Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancer. Int J Gynecol Cancer (2010) 0.96
Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol (2011) 0.96
A systematic review of psychological interventions for adolescents and young adults living with chronic illness. Health Psychol (2011) 0.96
Population pharmacokinetic estimation of tacrolimus apparent clearance in adult liver transplant recipients. Ther Drug Monit (2005) 0.95
Methodological considerations in the study of genetic discrimination. Community Genet (2004) 0.95
Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience. J Paediatr Child Health (2014) 0.95
Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial. Breast Cancer Res Treat (2013) 0.94
Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study. Cancer Epidemiol Biomarkers Prev (2004) 0.94
A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. Psychooncology (2008) 0.93
Reducing delay in the diagnosis of pregnancy-associated breast cancer: how imaging can help us. J Med Imaging Radiat Oncol (2011) 0.92
Intraoperative radiotherapy for early breast cancer: do health professionals choose convenience or risk? Radiat Oncol (2014) 0.92
Are videoconferenced consultations as effective as face-to-face consultations for hereditary breast and ovarian cancer genetic counseling? Genet Med (2011) 0.92
Australian general practitioners' preferences for managing the care of people diagnosed with cancer. Asia Pac J Clin Oncol (2012) 0.92
Inherited cancer susceptibility syndromes in paediatric practice. J Paediatr Child Health (2007) 0.92
Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost. Int J Radiat Oncol Biol Phys (2006) 0.91
Rates for mastectomy are lower in women attending a breast-screening programme. ANZ J Surg (2005) 0.91
Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Res (2005) 0.91
The tubal hypothesis of ovarian cancer: caution needed. Lancet Oncol (2011) 0.90
Understanding community beliefs of Chinese-Australians about cancer: initial insights using an ethnographic approach. Psychooncology (2005) 0.90
Process research and development for a tetrazole-based growth hormone secretagogue (GHS) pharmaceutical development candidate. J Org Chem (2009) 0.89
The virtual consultation: practitioners' experiences of genetic counseling by videoconferencing in Australia. Telemed J E Health (2010) 0.89
Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery. Fam Cancer (2012) 0.88
Ascertaining invasive breast cancer cases; the validity of administrative and self-reported data sources in Australia. BMC Med Res Methodol (2013) 0.88
Diagnosing cancer in the bush: a mixed methods study of GP and specialist diagnostic intervals in rural Western Australia. Fam Pract (2013) 0.88
Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer. Eur J Cancer (2006) 0.88
Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy. ANZ J Surg (2012) 0.87
Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer. PLoS One (2013) 0.86
Breast cancer in young women. Aust Fam Physician (2005) 0.86
Exploring existing and deliberated community perspectives of newborn screening: informing the development of state and national policy standards in newborn screening and the use of dried blood spots. Aust New Zealand Health Policy (2006) 0.85
The role of poly adenosine diphosphate ribose polymerase inhibitors in breast and ovarian cancer: current status and future directions. Asia Pac J Clin Oncol (2011) 0.85
Development and pilot testing of a fertility decision aid for young women diagnosed with early breast cancer. Breast J (2010) 0.85
Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. Clin Cancer Res (2003) 0.84
Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer. J Clin Oncol (2011) 0.84
Triple-negative breast cancer: making the most of a misnomer. Asia Pac J Clin Oncol (2012) 0.83
A growing dilemma--breast cancer and pregnancy. Aust Fam Physician (2002) 0.83
To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk. Genet Test Mol Biomarkers (2012) 0.83
Beliefs and perceptions about the causes of breast cancer: a case-control study. BMC Res Notes (2014) 0.82
The responses of research participants and their next of kin to receiving feedback of genetic test results following participation in the Australian Ovarian Cancer Study. Genet Med (2013) 0.82
Genetics and preventive health care. Aust Fam Physician (2007) 0.82
The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia. Fam Cancer (2013) 0.82
High levels of genomic aberrations in serous ovarian cancers are associated with better survival. PLoS One (2013) 0.82
Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer. Genet Med (2012) 0.81
When the risks are high: psychological adjustment among melanoma survivors at high risk of developing new primary disease. Qual Health Res (2012) 0.81
Investigating genetic discrimination in the Australian life insurance sector: the use of genetic test results in underwriting, 1999-2003. J Law Med (2007) 0.81